Executive Vice President, Investor Relations and Communications
Fleur brings over 20 years’ experience in investor relations, communications and capital markets gained primarily within the UK investment banking industry and the pharmaceuticals sector. During her career, she has brought strategic IR skills to both M&A situations and to companies undergoing growth and change. Fleur’s previous role was at Vectura Group plc, a FTSE 250 company listed on the London Stock Exchange focussed on airways diseases, where she held positions as director of communications and director of investor relations. She played an integral role in the acquisition of Activaero GmbH in 2014 and the merger with Skyepharma plc in 2016.